Facilitated By

San Antonio Medical Foundation

News

  • Puma Biotech Crashes After Diarrhea Risk is Linked to Breast Cancer Drug

    In an abstract for the 2016 San Antonio Breast Cancer Symposium in December, Puma said it was using the anti-diarrheal medicine loperamide for ...

  • Here's Why The Puma Biotechnology Inc (NYSE:PBYI) Pullback Might Be A Buy-In Opportunity

    Puma Biotechnology Inc (NYSE:PBYI) just announced its abstract for an upcoming 2016 San Antonio Breast Cancer Symposium (SABCS), which will ...

  • Cholesterol drug shows promise to help reverse heart disease

    The new ones are biotech drugs that are expensive to make — Repatha costs $14,000 a year and insurers often won't pay. They must be given as ...

  • Active biotech company shares in the news: Immunomedics Inc. (NASDAQ:IMMU), Trevena, Inc ...

    ... presentation at the 2016 San Antonio Breast Cancer Symposium (SABCS) to be held at the Henry B. Gonzalez Convention Center in San Antonio, ...

  • Sizzling Stock Alert - Puma Biotechnology, (NYSE:PBYI), Zimmer Biomet Holdings, (NYSE:ZBH)

    Puma Biotechnology Inc (NYSE:PBYI) traded 6,932,205 shares on last ... Symposium (SABCS), December 6 – 10, 2016, in San Antonio, Texas.